Paracetamol Suppository 150mg | Rectal Analgesic & Antipyretic for Fever

Paracetamol Suppository 150mg: What the Published Guidance Says

The three non-opioid analgesics named on the WHO Model List — paracetamol, ibuprofen and acetylsalicylic acid — in the full range of oral, rectal and injectable presentations, plus the wider NSAID family.

Paracetamol Suppository 150mg sits in the Analgesics & NSAIDs range. The notes below are the ones that most often change a specification, a label or a tender submission.

• Paracetamol is an antipyretic and analgesic — not an anti-inflammatory The Model List carries a footnote stating paracetamol is not recommended for anti-inflammatory use due to lack of proven benefit to that effect. Marketing copy that positions paracetamol as an anti-inflammatory is inconsistent with the WHO listing. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
• Fever control is part of severe-disease management MSF guidance on severe malaria directs paracetamol in the event of high fever only — a reminder that in febrile illness the antipyretic is supportive care, not the disease treatment. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
• A strength-confusion warning that matters commercially The Model List itself warns that the presence of both 120 mg/5 mL and 125 mg/5 mL paracetamol oral liquid strengths on the same market would cause confusion in prescribing and dispensing and should be avoided. Country programmes should therefore settle on one strength. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)

These points are quoted because they shape how Paracetamol Suppository 150mg is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Ordering Parameters for Paracetamol Suppository 150mg

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ibuprofen Suppository 50mg, Indomethacin Suppository 100mg, Naproxen Suppositories 250mg, Diclofenac Sodium 50mg, Mefenamic 250mg Capsules, Aspirin 300mg Tablets, Paracetamol Diphenhydramine Chlorphenamine Tablets, Ibuprofen 100mg Tablets.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Paracetamol Suppository 150mg is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

• Pack size: Individually sealed suppositories (blister or foil pouch); typically 10 or 12 suppositories per box. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store in a cool place (below 25°C) or refrigerate if required. Keep away from heat and direct sunlight. Keep suppositories in their sealed packaging until use..
• Shelf life: 36 months (unopened, when stored as directed). Stability data for the marketed pack is included in the dossier.
• Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
• Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
• Batch manufacturing and packaging records released for inspection on request during supplier audits.
• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.

This page describes Paracetamol Suppository 150mg as a product of the non-opioid analgesics and NSAIDs named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Products Commonly Ordered with Paracetamol Suppository 150mg

• Ibuprofen Suppository 50mg — 50mg
• Indomethacin Suppository 100mg — 100mg
• Naproxen Suppositories 250mg — 250mg
• Diclofenac Sodium 50mg — 50mg
• Mefenamic 250mg Capsules — 250mg
• Aspirin 300mg Tablets — 300mg

Browse the full Analgesics & NSAIDs range; all Suppositories; the complete product catalogue.